A 3D Learning Experience: Novel Combination Treatment Options and Sequencing Strategies for Personalized Management of Relapsed and/or Refractory Multiple Myeloma

 
Friday, December 6, 2019
7:30 AM – 9:30 AM

Location

Hilton Orlando
6001 Destination Parkway
Orlando, FL 32819
Meeting Room: Ballroom 4-6

 

REGISTER NOW!
Already Registered?
SIGN IN

 
 

WEBCAST DATE

Friday, December 6, 2019

07:30 AM Eastern    06:30 AM Central    05:30 AM Mountain    04:30 AM Pacific

Add to Calendar 12/06/2019 07:30 AM 12/06/2019 09:30 AM America/New_York A 3D Learning Experience: Novel Combination Treatment Options and Sequencing Strategies for Personalized Management of Relapsed and/or Refractory Multiple Myeloma A 3D Learning Experience: Novel Combination Treatment Options and Sequencing Strategies for Personalized Management of Relapsed and/or Refractory Multiple Myeloma Live Simulcast Med Learning Group info@medlearninggroup.com false MM/DD/YYYY atZOdzeAgzXtBkKLjmOo27579

 

PROGRAM FEATURES

  • 3D Glasses provided to all attendees
  • iPads provided to enhance learning experience
  • Create your own personalized poster
  • Interactive, case-based learning environment

FACULTY

Parameswaran Hari, MD, MRCP
Professor of Medicine
Medical College of Wisconsin
Milwaukee, WI

Hans Lee, MD
Assistant Professor
University of Texas
MD Anderson Cancer Center
Houston, TX

TARGET AUDIENCE

This initiative is designed to meet the educational needs of community and academic medical oncologists and advanced practitioners (NP/PA/PharmD) involved in the management of patients with MM.

LEARNING OBJECTIVES

After completing the educational activity, learners should be better able to:

  • Discuss the MOAs and clinical profiles of new and emerging treatment options for patients with R/R MM
  • Review evidence-based guideline recommendations on treatment selection and sequencing for patients with R/R MM
  • Recognize the disease-, treatment-, and patient-related factors that affect risk stratification and the selection and sequencing of novel drug combination therapies for patients with R/R MM

ACCREDITATION STATEMENT

Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
 
 

CREDIT DESIGNATION STATEMENT

Med Learning Group designates this live activity for a maximum of 2.0 AMA Category 1 Credit(s)TM.
 
Physicians should claim only the credit commensurate with the extent of their participation in the live activity.

NURSING CREDIT INFORMATION

Purpose: This program would be beneficial for nurses involved in the care of patients with MM.

CNE Credits: 2.0 ANCC Contact Hour(s)

ACCREDITATION STATEMENT

Ultimate Medical Academy/CCM is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation. Awarded 2.00 contact hour(s) of continuing nursing education of RNs and APNs.

DISCLOSURE POLICY STATEMENT

In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial Support, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in a MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.

DISCLOSURE OF UNLABELED USE

Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.

DISCLAIMER

Med Learning Group makes every effort to develop CME activities that are scientifically based. This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.

For CME questions, please contact Med Learning Group at info@medlearninggroup.com.

Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at www.medlearninggroup.com/privacy-policy/

AMERICANS WITH DISABILITIES ACT

Event staff will be glad to assist you with any special needs (eg, physical, dietary, etc.). Please contact Med Learning Group prior to the live event at info@medlearninggroup.com

 

WEBCAST REGISTRATION

Please use the following form to register for this webcast. You will receive an email confirmation shortly after you complete the registration.

If you are unable to register online or do not receive your confirmation email after registering, please email us at support@performedia.com.

Registration Form


*Required field

WEBCAST SIGNIN

Please enter your registered email and click the Sign In button to watch the Live Simulcast.

If you are unable to sign in or watch the live simulcast, please email us at support@performedia.com.

 

 

 

Copyright © 2019 Med Learning Group. All rights reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Med Learning Group is prohibited.